Practical Guidelines for the Recognition and Diagnosis of Dementia

被引:129
作者
Galvin, James E. [1 ]
Sadowsky, Carl H. [2 ,3 ]
机构
[1] NYU, Langone Sch Med, Ctr Excellence Brain Aging, New York, NY 10016 USA
[2] Nova SE Univ, Div Neurol, Ft Lauderdale, FL 33314 USA
[3] Palm Beach Neurol, Premiere Res Inst, W Palm Beach, FL USA
关键词
Dementia; Diagnosis; Diagnostic Techniques and Procedures; Guidelines; QUALITY STANDARDS SUBCOMMITTEE; MONTREAL COGNITIVE ASSESSMENT; MANAGING ALZHEIMERS-DISEASE; BRIEF INFORMANT INTERVIEW; PRIMARY-CARE PHYSICIANS; OLDER-ADULTS; MINI-COG; CHOLINESTERASE-INHIBITORS; PRACTICE PARAMETER; SCREENING TOOL;
D O I
10.3122/jabfm.2012.03.100181
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To date, user-friendly, practical guidelines for dementia have not been available for busy family physicians. However, the growing number of patients with dementia means that primary care physicians will have an increasingly important role in the diagnosis and subsequent management of dementia. This article provides practical guidance for the recognition and diagnosis of dementia and is aimed at family physicians, who are usually the first clinicians to whom patients present with dementia symptoms. Because Alzheimer disease (AD) is the most common form of dementia, this condition is the main focus of this article. We review the pathophysiology of AD and discuss recommended diagnostic protocols and the importance of early diagnosis. An AD diagnostic algorithm is provided, with clearly defined steps for screening and diagnosing AD and assessing daily functioning, behavioral symptoms, and caregiver status. (J Am Board Fam Med 2012;25:367-382.)
引用
收藏
页码:367 / 382
页数:16
相关论文
共 72 条
  • [61] Cognitive impairment, chronic disease burden, and functional disability: A population study of older Italians
    Scanlan, James M.
    Binkin, Nancy
    Michieletto, Federica
    Lessig, Mary
    Zuhr, Elizabeth
    Borson, Soo
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 15 (08) : 716 - 724
  • [62] The public health impact of Alzheimer's disease 2000-2050: Potential implication of treatment advances
    Sloane, PD
    Zimmerman, S
    Suchindran, C
    Reed, P
    Wang, L
    Boustani, M
    Sudha, S
    [J]. ANNUAL REVIEW OF PUBLIC HEALTH, 2002, 23 : 213 - 231
  • [63] Steffens David C, 2005, Am J Alzheimers Dis Other Demen, V20, P367, DOI 10.1177/153331750502000611
  • [64] Neuropsychological testing - Helpful or harmful?
    Teng, EL
    Manly, JJ
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2005, 19 (04) : 267 - 271
  • [65] Diagnosing dementia with confidence by GPs
    van Hout, Hein P. J.
    Vernooij-Dassen, Myrra J.
    Stalman, Wim A. B.
    [J]. FAMILY PRACTICE, 2007, 24 (06) : 616 - 621
  • [66] Vestergaard M., 2006, NanoBiotechnology, V2, P5, DOI DOI 10.1007/S12030-006-0002-Y
  • [67] Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
    Waldemar, G.
    Dubois, B.
    Emre, M.
    Georges, J.
    McKeith, I. G.
    Rossor, M.
    Scheltens, P.
    Tariska, P.
    Winblad, B.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (01) : E1 - E26
  • [68] The utility of PET brain imaging in the initial evaluation of dementia
    Weaver, Jonathan D.
    Espinoza, Randall
    Weintraub, Nancy T.
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2007, 8 (03) : 150 - 157
  • [69] Implications of the Facing Dementia Survey for health care professionals across Europe
    Wilkinson, D
    Sganga, A
    Stave, C
    O'Connell, B
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 : 27 - 31
  • [70] Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease - A review with methodological considerations
    Wimo, A
    [J]. DRUGS & AGING, 2004, 21 (05) : 279 - 295